Kelly M. Brooks
Brisbane, QLD, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Large distant deletion disrupts CDKN2A enhancer and predisposes to melanoma.
Journal: medRxiv : the preprint server for health sciences
Published: July 02, 2026
Genetic architecture of multiple primary cutaneous melanoma in the absence of high-penetrance susceptibility genes.
Journal: The Journal of investigative dermatology
Published: January 14, 2026
GWAS meta-analysis provides new insights into uveal melanoma risk.
Journal: British journal of cancer
Published: December 04, 2025
Rare Germline Variants in CDKN2A-Negative Children and Adolescents With Cutaneous Melanoma.
Journal: Pigment cell & melanoma research
Published: June 23, 2025
Iris melanoma in an Australian cohort.
Journal: Clinical & experimental ophthalmology
Published: June 07, 2024
Germline Variants in Patients Affected by Both Uveal and Cutaneous Melanoma.
Journal: Pigment cell & melanoma research
Published: May 12, 2024
Tigilanol tiglate is an oncolytic small molecule that induces immunogenic cell death and enhances the response of both target and non-injected tumors to immune checkpoint blockade.
Journal: Journal for immunotherapy of cancer
Published: March 31, 2024
Longitudinal gut microbiome changes in immune checkpoint blockade-treated advanced melanoma.
Journal: Nature medicine
Published: June 20, 2023
Comparative Genomics Provides Etiologic and Biological Insight into Melanoma Subtypes.
Journal: Cancer discovery
Published: May 24, 2022
Choroidal melanoma with synchronous Fuchs' adenoma and novel ATRX mutation.
Journal: International journal of retina and vitreous
Published: July 24, 2021
Definition of Biologically Distinct Groups of Conjunctival Melanomas According to Etiological Factors and Implications for Precision Medicine.
Journal: Cancers
Published: July 06, 2021
Last Updated: 09/26/2026